NDC 15631-0180

ERIGERON CANADENSIS

Erigeron Canadensis

ERIGERON CANADENSIS is a Oral Pellet in the Human Otc Drug category. It is labeled and distributed by Rxhomeo Private Limited D.b.a. Rxhomeo, Inc. The primary component is Conyza Canadensis.

Product ID15631-0180_58453b1a-0310-4efc-8323-8608bcfe5bcd
NDC15631-0180
Product TypeHuman Otc Drug
Proprietary NameERIGERON CANADENSIS
Generic NameErigeron Canadensis
Dosage FormPellet
Route of AdministrationORAL
Marketing Start Date2015-10-02
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameRxhomeo Private Limited d.b.a. Rxhomeo, Inc
Substance NameCONYZA CANADENSIS
Active Ingredient Strength1 [hp_X]/1
NDC Exclude FlagE
Listing Certified Through2018-12-31

Packaging

NDC 15631-0180-0

100 PELLET in 1 PACKAGE (15631-0180-0)
Marketing Start Date2018-01-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 15631-0180-2 [15631018002]

ERIGERON CANADENSIS PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-19

NDC 15631-0180-3 [15631018003]

ERIGERON CANADENSIS PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-19

NDC 15631-0180-4 [15631018004]

ERIGERON CANADENSIS PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-19

NDC 15631-0180-5 [15631018005]

ERIGERON CANADENSIS PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-19

NDC 15631-0180-1 [15631018001]

ERIGERON CANADENSIS PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-19

NDC 15631-0180-0 [15631018000]

ERIGERON CANADENSIS PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-19

Drug Details

Active Ingredients

IngredientStrength
CONYZA CANADENSIS1 [hp_X]/1

OpenFDA Data

SPL SET ID:980ea860-9401-4ee7-ad65-ef486dca4181
Manufacturer
UNII

NDC Crossover Matching brand name "ERIGERON CANADENSIS" or generic name "Erigeron Canadensis"

NDCBrand NameGeneric Name
0220-1900Erigeron canadensisERIGERON CANADENSIS
15631-0180ERIGERON CANADENSISERIGERON CANADENSIS
37662-0703Erigeron CanadensisErigeron Canadensis
37662-0704Erigeron CanadensisErigeron Canadensis
37662-0705Erigeron CanadensisErigeron Canadensis
37662-0706Erigeron CanadensisErigeron Canadensis
37662-0707Erigeron CanadensisErigeron Canadensis
37662-0708Erigeron CanadensisErigeron Canadensis
37662-0709Erigeron CanadensisErigeron Canadensis
37662-0710Erigeron CanadensisErigeron Canadensis
68428-369Erigeron canadensisERIGERON CANADENSIS
71919-271Erigeron canandensisERIGERON CANADENSIS

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.